Effects of orange juice intake on Doxorubicin-induced hepatotoxicity and nephrotoxicity in Wistar rats
DOI:
https://doi.org/10.34117/bjdv10n9-012Keywords:
doxorubicin, orange juice, hepatotoxicity, nephrotoxicityAbstract
Considering that doxorubicin (DOXO) is an anticancer agent with severe adverse effects, this preclinical study investigated the protective effect of ‘pera’ orange juice (POJ) intake on DOXO-induced hepatic and renal toxicities. To this end, male Wistar rats were treated with DOXO in chronic (4.0 mg/kg weekly for four weeks) and acute (16.0 mg/kg in the fourth week) regimens. The experimental groups received filtered water or pasteurized POJ. After euthanasia, livers and kidneys were evaluated histologically and immunohistochemically for Ki-67 and histone γ-H2A.X markers, and their data were analyzed by One-Way ANOVA followed by Tukey’s a posteriori test. In this way, it was observed that DOXO caused weight loss, histological changes and increased damage markers. POJ reduced these changes only in chronic treatment, which allows us to conclude that the orange juice may attenuate the hepatotoxicity and nephrotoxicity of DOXO at low and fractionated doses.
References
AISSA, A. F. et al. Comparative study of β-carotene and microencapsulated β-carotene: Evaluation of their genotoxic and antigenotoxic effects. Food and Chemical Toxicology, v. 50, n. 5, p. 1418–1424, 2012.
AKOLKAR, G. et al. Vitamin C mitigates oxidative/nitrosative stress and inflammation in Doxorubicin-Induced cardiomyopathy. American Journal of Physiology - Heart and Circulatory Physiology, v. 313, n. 4, p. 795–809, 2017.
CHEN, X. et al. Protective effect of berberine on doxorubicin-induced acute hepatorenal toxicity in rats. Molecular Medicine Reports, v. 13, n. 5, p. 3953–3960, 2016.
CHUNG, J. J. et al. Single-cell transcriptome profiling of the kidney glomerulus identifies key cell types and reactions to injury. Journal of the American Society of Nephrology, v. 31, n. 10, p. 2341–2354, 2020.
DALGÅRD, C. et al. Supplementation with orange and blackcurrant juice, but not vitamin E, improves inflammatory markers in patients with peripheral arterial disease. British Journal of Nutrition, v. 101, n. 2, p. 263–269, 2009.
DAMIANI, R. M. et al. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone. Archives of Toxicology, v. 90, n. 9, p. 2063–2076, 2016.
DJABIR, Y. Y. et al. Potential roles of Kleinhovia hospital L. leaf extract in reducing doxorubicin acute hepatic, cardiac and renal toxicities in rats. Pharmacognosy Research, v. 9, n. 2, p. 168–173, 2017.
EL-SAYED, E. S. M.; MANSOUR, A. M.; EL-SAWY, W. S. Protective effect of proanthocyanidins against doxorubicin-induced nephrotoxicity in rats. Journal of Biochemical and Molecular Toxicology, v. 31, n. 11, p. 1–6, 2017.
EWER, M. S.; EWER, S. M. Cardiotoxicity of anticancer treatments: What the cardiologist needs to know. Nature Reviews Cardiology, v. 7, n. 10, p. 564–575, 2010.
FRAZIER, K. S. et al. Proliferative and nonproliferative lesions of the rat and mouse urinary system. Toxicologic Pathology, v. 40, n. 4S, p. 14S–86S, 2012.
GHANIM, H. et al. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and toll-like receptor expression. American Journal of Clinical Nutrition, v. 91, n. 4, p. 940–949, 2010.
GUO, R. M. et al. Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells. Molecular Medicine Reports, v. 8, n. 2, p. 603–608, 2013.
HENRIKSEN, P. A. Anthracycline cardiotoxicity: An update on mechanisms, monitoring and prevention. Heart, v. 104, n. 12, p. 971–977, 2018.
INJAC, R. et al. Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer. Biomaterials, v. 30, n. 6, p. 1184–1196, 2009.
JACEVIC, V. et al. Fullerenol nanoparticles prevents doxorubicin-induced acute hepatotoxicity in rats. Experimental and Molecular Pathology, v. 102, n. 2, p. 360–369, 2017.
KALENDER, Y.; YEL, M.; KALENDER, S. Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats: The effects of vitamin E and catechin. Toxicology, v. 209, n. 1, p. 39–45, 2005.
KUMAR, D. et al. Apoptosis in Adriamycin Cardiomyopathy and Its Modulation by Probucol. Antioxidants & Redox Signaling, v. 3, n. 1, p. 135–145, fev. 2001.
LI, A. et al. Elucidating the time-dependent changes in the urinary metabolome under doxorubicin-induced nephrotoxicity. Toxicology Letters, v. 319, p. 204–212, 2020.
LI, S. et al. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction. Oxidative Medicine and Cellular Longevity, v. 2014, p. 1–16, 2014.
LITTERST, C. L. et al. Local and systemic toxicity resulting from large-volume ip administration of doxorubicin in the rat. Cancer treatment reports, v. 66, n. 1, p. 157–161, 1982.
LIU, X. et al. Citronellal ameliorates doxorubicin-induced hepatotoxicity via antioxidative stress, antiapoptosis, and proangiogenesis in rats. Journal of Biochemical and Molecular Toxicology, v. 35, n. 2, p. 1–9, 2021.
LLESUY, S. F.; ARNAIZ, S. L. Hepatotoxicity of mitoxantrone and doxorubicin. Toxicology, v. 63, n. 2, p. 187–198, 1990.
MILES, E. A.; CALDER, P. C. Effects of Citrus Fruit Juices and Their Bioactive Components on Inflammation and Immunity: A Narrative Review. Frontiers in Immunology, v. 12, p. 1–18, 2021.
NAVARRO-HORTAL, M. D. et al. Role of flavonoids against adriamycin toxicity. Food and Chemical Toxicology, v. 146, p. 1–18, 2020.
OLIVEIRA, B. C. et al. Influência do Consumo de Suco de Laranja (Citrus Sinensis) na Remodelação Cardíaca de Ratos Submetidos a Infarto do Miocárdio. Arquivos Brasileiros de Cardiologia, v. 116, n. 6, p. 11271136, 2021.
PRASANNA, P. L.; RENU, K.; GOPALAKRISHNAN, A. V. New molecular and biochemical insights of doxorubicin-induced hepatotoxicity. Life Sciences, v. 250, p. 1–9, 2020.
PRŠA, P. et al. The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics. Biochemical Pharmacology, v. 173, p. 1–12, 2020.
PUGAZHENDHI, A. et al. Toxicity of Doxorubicin (Dox) to different experimental organ systems. Life Sciences, v. 200, p. 26–30, 2018.
QI, W. et al. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling. Biomedicine and Pharmacotherapy, v. 122, p. 1–12, 2020.
RIBEIRO, A. P. D. et al. Pera orange (Citrus sinensis) and Moro orange (Citrus sinensis (L.) Osbeck) juices attenuate left ventricular dysfunction and oxidative stress and improve myocardial energy metabolism in acute doxorubicin-induced cardiotoxicity in rats. Nutrition, v. 91–92, p. 1–9, 2021.
SAAD, S. Y.; NAJJAR, T. A.; AL-RIKABI, A. C. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacological Research, v. 43, n. 3, p. 211–218, 2001.
SAWYER, D. B. Anthracyclines and Heart Failure. New England Journal of Medicine, v. 368, n. 12, p. 1154–1156, 2013.
SCHIRRMACHER, V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review). International Journal of Oncology, v. 54, n. 2, p. 407–419, 2019.
SU, Z. et al. Protective effects of madecassoside against Doxorubicin induced nephrotoxicity in vivo and in vitro. Scientific Reports, v. 5, p. 1–14, 2015.
SUN, X. P. et al. Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart. Archives of Pharmacal Research, v. 40, n. 7, p. 875–883, 2017.
SWAIN, S. M.; WHALEY, F. S.; EWER, M. S. Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer, v. 97, n. 11, p. 2869–2879, 2003.
THOOLEN, B. et al. Comparative histomorphological review of rat and human hepatocellular proliferative lesions. Journal of Toxicologic Pathology, v. 25, n. 3, p. 189–199, 2012.
THORN, C. F. et al. Doxorubicin pathways: Pharmacodynamics and adverse effects. Pharmacogenetics and Genomics, v. 21, n. 7, p. 440–446, 2011.
TULUBAS, F. et al. The protective effects of ω-3 fatty acids on doxorubicin-induced hepatotoxicity and nephrotoxicity in rats. Toxicology and Industrial Health, v. 31, n. 7, p. 638–644, 2015.
VARELA-LÓPEZ, A. et al. An update on the mechanisms related to cell death and toxicity of doxorubicin and the protective role of nutrients. Food and Chemical Toxicology, v. 134, p. 1–19, 2019.
VEJPONGSA, P.; YEH, E. T. H. Prevention of anthracycline-induced cardiotoxicity: Challenges and opportunities. Journal of the American College of Cardiology, v. 64, n. 9, p. 938–945, 2014.
VILE, G. F.; WINTERBOURN, C. C. Inhibition of adriamycin-promoted microsomal lipid peroxidation by β-carotene, α-tocopherol and retinol at high and low oxygen partial pressures. FEBS Letters, v. 238, n. 2, p. 353–356, 1988.
VOLKOVA, M.; RUSSELL, R. Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment. Current Cardiology Reviews, v. 7, n. 4, p. 214–220, 2012.
YEH, C. C. et al. The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sciences, v. 80, n. 20, p. 1821–1831, 2007.
